Alteogen, Stock Price Down -8.49% at This Hour... Foreigners Net Buy 44,533 Shares in Last 5 Days

Alteogen is trading at 259,900 KRW as of 12:31 PM on the 29th, down 8.49% from the previous day. The trading volume is 569,915 shares, which is 102.29% of the previous day's volume. Alteogen is known as a biosimilar developer.

On June 25, Lee Dong-geon, a researcher at Shinhan Financial Investment, stated, "A large-scale license agreement worth 4.7 trillion KRW was signed with a global top 10 pharmaceutical company. This contract covers a total of six targets, with a structure to receive up to 776.3 billion KRW in milestones and royalties per target. Attention is drawn to the scalability of the company that signed the largest platform license agreement in Korea. In other words, the commercialization potential is higher compared to new drugs, and since only clinical phases 1 and 3 are conducted, the required time is significantly shorter." He set Alteogen’s target price at 340,000 KRW.

Over the past five days, individual investors have net sold 11,101 shares of Alteogen, while foreigners and institutions have net bought 44,533 shares and net sold 19,689 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.